...
首页> 外文期刊>International Journal of Pharmaceutical Sciences and Research >DEVELOPMENT AND OPTIMIZATION OF EFFERVESCENT TABLETS OF PROMETHAZINE
【24h】

DEVELOPMENT AND OPTIMIZATION OF EFFERVESCENT TABLETS OF PROMETHAZINE

机译:丙戊嗪泡腾片的研制与优化

获取原文
           

摘要

The objective of present study was to develop effervescent tablets of promethazine (PMZ) for the treatment of emesis. Effervescent tablets were prepared by direct compression method and were optimized using 32 full factorial design. Amount to sodium starch glycolate(X1) and amount of sodium bicarbonate (X2) were selected as independent variables, whereas disintegration time (Y1), amount of carbon dioxide (Y2) and drug release in 5 minutes (Y3) were selected as dependent variables. All the batches were also evaluated for general post compression evaluation of tablet such as- weight variation, thickness, friability and hardness. From the results of design batches, best batch was selected and evaluated for in vivo pharmacokinetic study in a rabbit model. The disintegration time ranged from 58.67±0.27sec to 228.67± 0.67sec while amount of carbon dioxide ranged from 0.1±0.082 gm to 0.29±0.061gm in all the design batches. From the results of design batches, batch F9 was selected as optimized batch due to higher amount of carbon dioxide released and faster drug release as compared to other batches. Batch B4 was showing higher AUC and Cmax while lower tmax as compared to drug suspension while performing in vivo study of optimized batch in a rabbit model. The study concluded that the combination of sodium starch glycolate and sodium bicarbonate approach for development of effervescent tablet aids to achieve faster disintegration and faster drug release property for PMZ.
机译:本研究的目的是开发用于治疗呕吐的异丙嗪泡腾片(PMZ)。采用直接压片法制备泡腾片,并采用3 2 全因子设计对其进行优化。自变量选择乙醇酸淀粉钠(X1)和碳酸氢钠(X2)作为因变量,崩解时间(Y1),二氧化碳(Y2)和5分钟内药物释放(Y3)作为因变量。 。还评估了所有批次的片剂的一般压缩后评价,例如重量变化,厚度,脆性和硬度。从设计批次的结果中,选择最佳批次并评估其在兔模型中的体内药代动力学研究。在所有设计批次中,崩解时间为58.67±0.27sec至228.67±0.67sec,而二氧化碳的量为0.1±0.082gm至0.29±0.061gm。从设计批次的结果来看,由于与其他批次相比释放的二氧化碳量更高且药物释放速度更快,因此将批次F9选择为优化批次。在兔子模型中进行优化批次的体内研究时,与药物悬浮液相比,批次B4显示更高的AUC和C max ,而更低的t max 。该研究得出结论,将乙醇酸淀粉钠和碳酸氢钠的组合用于泡腾片剂的开发有助于实现PMZ的更快崩解和更快的药物释放性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号